NOCIL (NOCIL) Q3 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 25/26 earnings summary
11 Sep, 2026Executive summary
Domestic volumes grew at a high single-digit rate in Q3 FY26, driven by improved demand and GST 2.0, while international volumes declined due to seasonal effects and U.S. tariffs.
Largest rubber chemicals manufacturer in India with global recognition, focusing on sustainable growth, green chemistry, and responsible care.
Strong export strategy and China+1 positioning to reduce reliance on China and ensure supply stability.
Board approved unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, reviewed by statutory auditors with no material misstatements.
Anti-dumping petitions filed for key products, with investigations underway.
Financial highlights
Q3 FY26 net revenue: INR 316 crore, down INR 5 crore sequentially from Q2 FY26; nine months revenue: INR 973 crore vs. INR 1,053 crore prior year.
Q3 FY26 operating EBITDA: INR 27 crore (Q2: INR 22 crore); EBITDA margin: 8.5%.
Q3 FY26 PAT: INR 9 crore (Q2: INR 12 crore); nine months PAT: INR 39 crore vs. INR 82 crore prior year.
Standalone revenue for Q3 FY26 was ₹315.84 crore; nine-month revenue was ₹972.62 crore, down from ₹1,053.00 crore year-over-year.
Exceptional item of ₹5 crore in Q3 FY26 due to new labour codes.
Outlook and guidance
FY26 volume growth expected at 3%-4% despite H1 decline; double-digit volume growth guided for FY27, driven by domestic buoyancy and recovery in U.S. exports.
U.S. export volumes, which dropped to 50% of pre-tariff levels, are expected to recover within 2-3 months.
New TDQ antioxidant capacity to begin production trials in H1 2026, with ramp-up in FY27 and significant contribution by FY28.
New products in pipeline expected to contribute 10%-12% of volumes by FY28.
The group continues to monitor regulatory developments regarding labour codes and will adjust accounting as needed.
Latest events from NOCIL
- Q1 FY25 revenue grew 4% to ₹372.17 crore, but margins and profit declined amid expansion.NOCIL
Q1 24/25 - Q2 FY25 net profit surged 55% year-over-year, with export growth and deferred tax credits.NOCIL
Q2 24/25 - Q3 FY25 saw lower revenue and profit, but export growth and capex signal recovery ahead.NOCIL
Q3 24/25 - FY25 saw lower revenue and profit, strong export growth, and a Rs.2/share dividend recommended.NOCIL
Q4 24/25 - Revenue and profit declined, but expansion and sustainability initiatives continue amid market headwinds.NOCIL
Q1 25/26 - FY26 volume grew 3%, but profit and revenue fell; CapEx funded internally; dividend proposed.NOCIL
Q4 25/26 - Revenue and profit declined amid global headwinds, but expansion and efficiencies continue.NOCIL
Q2 25/26 - Q1 FY 2027 revenue grew 20% YoY to INR 403 crore, with net profit up 63% and strong margins.NOCIL
Q1 26/27